Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TQ0277 |
Pralsetinib
普拉替尼,Blu667 |
c-RET | Apoptosis; Tyrosine Kinase/Adaptors |
Pralsetinib (Blu667) 是高效的、选择性的RET 抑制剂。它能够抑制 WT RET (IC50:0.4 nM),RET 突变体 V804L (IC50:0.3 nM),V804M (IC50:0.4 nM),M918T (IC50:0.4 nM) 和 CCDC6-RET (IC50:0.4 nM) 的融合。 | |||
TQ0277L |
Pralsetinib HCl (2097132-94-8 free base)
Pralsetinib HCl,Pralsetinib hydrochloride,BLU-667,BLU667,BLU 667 |
||
Pralsetinib is a selective and next-generation RET inhibitor (IC50: 0.3-0.4 nM for WT RET, RET mutants V804L, V804M, M918T, and CCDC6-RET fusion). BLU-667 is an effective and selective inhibitor of RET mutations, fusions, and predicted resistant mutants. | |||
T10823 |
trans-Pralsetinib
cis-Pralsetinib,cis-BLU-667 |
c-RET | Apoptosis; Tyrosine Kinase/Adaptors |
trans-Pralsetinib (trans-BLU-667) is an inhibitor of rearranged during transfection (RET). |